Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 GBX | 0.00% | 0.00% | +9.52% |
Apr. 17 | Bivictrix granted FDA orphan drug status for rare cancer treatment | AN |
Apr. 17 | BiVictriX Wins US FDA's Orphan Drug Status for Blood Cancer Treatment | MT |
Quotes 5-day view
Delayed Quote London S.E.2024-05-13 | 2024-05-14 | 2024-05-15 | 2024-05-16 | 2024-05-17 | |
---|---|---|---|---|---|
Last | 11.5 p | 11.5 p | 11.5 p | 11.5 p | 11.5 p |
Volume | 0 | 10 000 | 0 | 67 | 0 |
Change | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Opening | 11.50 | 11.50 | 11.50 | 11.50 | 11.5 |
High | 11.50 | 10.50 | 11.50 | 12.00 | 11.5 |
Low | 11.50 | 10.50 | 11.50 | 12.00 | 11.5 |
Performance
6 months | -4.17% | ||
Current year | +9.52% | ||
1 year | -23.33% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
0.00% | 0.00% | +9.52% | -23.33% | 12.03M | ||
+0.48% | +13.64% | +34.05% | +6.16% | 50.85B | ||
-1.19% | -0.78% | +0.38% | +20.31% | 42.82B | ||
+0.34% | +0.57% | +49.62% | -6.44% | 42.03B | ||
-0.78% | +0.95% | -4.96% | +13.92% | 29.55B | ||
-0.49% | -0.58% | +10.77% | +48.85% | 26.11B | ||
-1.23% | -0.31% | -21.63% | -22.37% | 19.13B | ||
+1.38% | +3.55% | +8.58% | +2.12% | 13.05B | ||
-0.86% | -0.13% | +27.13% | +86.27% | 12.16B | ||
+0.53% | +3.57% | +24.48% | +26.61% | 12.08B | ||
-1.85% | -3.23% | -6.62% | +12.18% | 11.58B | ||
-0.32% | +5.11% | +2.38% | -1.08% | 10.2B | ||
-0.93% | +8.63% | +39.38% | -1.31% | 7.58B | ||
-1.17% | -1.48% | +13.96% | +93.02% | 6.68B | ||
-1.89% | -4.62% | +3.67% | -38.72% | 6.54B | ||
+2.01% | +6.27% | +38.02% | +52.66% | 6.43B | ||
Average | -0.41% | +2.01% | +14.30% | +16.80% | ||
Weighted average by Cap. | -0.35% | +2.38% | +16.51% | +14.81% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +9.52% | ||
2023 | -38.24% | ||
2022 | -42.37% | ||
2021 | +15.69% |
- Stock Market
- Equities
- BVX Stock
- Quotes BiVictriX Therapeutics Plc